UTI; Rash; This is a spontaneous report from a contactable other hcp. An 85-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, dose 2 via an unspecified route of administration in arm right on 21Apr2021 11:00 (Lot Number: EW0170; Expiration Date: 31Aug2021) as SINGLE DOSE for covid-19 immunisation. Dose 1 via unspecified route of administration in upper right arm on 30Mar2021 11:00 (Lot number ER8737; Expiry date 31Jul2021). Medical history included ongoing arthritis, tibia and leg swollen unknown if ongoing, ongoing atrial fibrillation, spinal deformity, cardiac pacemaker insertion, open heart surgery from 2021 to an unknown date, ongoing pain, bone disorder, muscle disorder, dyspepsia from an unknown date and unknown if ongoing, body height decreased from an unknown date and unknown if ongoing, she has started shrinking but this is clarified as an event to have started prior to vaccine. Concomitant medications included diltiazem (DILTIAZEM) taken for an unspecified indication from Nov2020 and ongoing; furosemide (FUROSEMIDE) taken for an unspecified indication from 2020, tramadol (TRAMADOL) taken for pain from an unspecified date in Jan2021 and ongoing; simvastatin (SIMVASTATIN) taken for cardiac disorder from an unspecified start date and ongoing; losartan (LOSARTAN) taken for an unspecified indication from an unspecified start date and ongoing; potassium chloride (POTASSIUM CHLORIDE) taken for an unspecified indication from an unspecified start date and ongoing; magnesium (MAGNESIUM) taken for bone disorder, muscle disorder from an unspecified start date and ongoing; zolpidem (ZOLPIDEM) taken for sleep disorder from an unspecified start date and ongoing; gabapentin (GABAPENTIN) taken for pain from an unspecified start date and ongoing; Bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]) taken for dyspepsia from an unspecified start date and ongoing; ciprofloxacin (CIPROFLOXACIN) taken for urinary tract infection from May2021 and ongoing. After the second vaccine, on 21Apr2021, she started to break out all down her legs and arms. The event began on 28Apr2021, she elaborated that the rash they come to a head, crust over and then that comes off and sometimes there is a little blood, but they don't hurt. The patient does not see more of them and her daughter looked and did not see more. When asked the height, the patient states she was 5.7 that she has started shrinking but this is clarified as an event to have started prior to vaccine. Patient also experienced UTI (urinary tract infection) on an unspecified date in May2021. The patient elaborated that the spots are the only thing different. Her rash was scattered from her hands to her shoulders on both arms, also on her forehead, left face, near her left eye, and going into her inguinal area and on the insides of her legs and going down to the bottom too. Patient remarked she picks at them, which she knows was not good. This has been the same since the first week it started. Therapeutic measures were taken as a result of UTI on Zolpidem 12.5 mg ER, tablet once at bedtime. The patient has not been able to refill the medication because it was a controlled substance and was only able to get a 30-day supply. The caller does not have access to NDC, lot or expiration. The patient takes Gabapentin 300 mg once a day, 100 mg three times a day, tablet, NDC, lot, number unknown. Outcome of the events was not recovered.  Follow-up (28Jun2021): Follow-up attempts completed. No further information expected.